Haptoglobin-2 variant increases susceptibility to acute respiratory distress syndrome during sepsis

V. Eric Kerchberger, Julie A. Bastarache, Ciara M. Shaver, Hiromasa Nagata, J. Brennan McNeil, Stuart R. Landstreet, Nathan D. Putz, Wen Kuang Yu, Jordan Jesse, Nancy E. Wickersham, Tatiana N. Sidorova, David R. Janz, Chirag R. Parikh, Edward D. Siew, Lorraine B. Ware

Research output: Contribution to journalArticle

Abstract

Acute respiratory distress syndrome (ARDS) is an inflammatory lung disorder that frequently complicates critical illness and commonly occurs in sepsis. Although numerous clinical and environmental risk factors exist, not all patients with risk factors develop ARDS, raising the possibility of genetic underpinnings for ARDS susceptibility. We have previously reported that circulating cell-free hemoglobin (CFH) is elevated during sepsis, and higher levels predict worse outcomes. Excess CFH is rapidly scavenged by haptoglobin (Hp). A common HP genetic variant, HP2, is unique to humans and is common in many populations worldwide. HP2 haptoglobin has reduced ability to inhibit CFH-mediated inflammation and oxidative stress compared with the alternative HP1. We hypothesized that HP2 increases ARDS susceptibility during sepsis when plasma CFH levels are elevated. In a murine model of sepsis with elevated CFH, transgenic mice homozygous for Hp2 had increased lung inflammation, pulmonary vascular permeability, lung apoptosis, and mortality compared with wild-Type mice. We then tested the clinical relevance of our findings in 496 septic critically ill adults, finding that HP2 increased ARDS susceptibility after controlling for clinical risk factors and plasma CFH. These observations identify HP2 as a potentially novel genetic ARDS risk factor during sepsis and may have important implications in the study and treatment of ARDS.

Original languageEnglish
Article numbere131206
JournalJCI Insight
Volume4
Issue number21
DOIs
Publication statusPublished - 2019 Nov 1

Fingerprint

Haptoglobins
Adult Respiratory Distress Syndrome
Sepsis
Hemoglobins
Plasma Cells
Critical Illness
Lung
Capillary Permeability
Transgenic Mice
Pneumonia
Oxidative Stress
Apoptosis
Inflammation
Mortality
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Eric Kerchberger, V., Bastarache, J. A., Shaver, C. M., Nagata, H., Brennan McNeil, J., Landstreet, S. R., ... Ware, L. B. (2019). Haptoglobin-2 variant increases susceptibility to acute respiratory distress syndrome during sepsis. JCI Insight, 4(21), [e131206]. https://doi.org/10.1172/jci.insight.131206

Haptoglobin-2 variant increases susceptibility to acute respiratory distress syndrome during sepsis. / Eric Kerchberger, V.; Bastarache, Julie A.; Shaver, Ciara M.; Nagata, Hiromasa; Brennan McNeil, J.; Landstreet, Stuart R.; Putz, Nathan D.; Kuang Yu, Wen; Jesse, Jordan; Wickersham, Nancy E.; Sidorova, Tatiana N.; Janz, David R.; Parikh, Chirag R.; Siew, Edward D.; Ware, Lorraine B.

In: JCI Insight, Vol. 4, No. 21, e131206, 01.11.2019.

Research output: Contribution to journalArticle

Eric Kerchberger, V, Bastarache, JA, Shaver, CM, Nagata, H, Brennan McNeil, J, Landstreet, SR, Putz, ND, Kuang Yu, W, Jesse, J, Wickersham, NE, Sidorova, TN, Janz, DR, Parikh, CR, Siew, ED & Ware, LB 2019, 'Haptoglobin-2 variant increases susceptibility to acute respiratory distress syndrome during sepsis', JCI Insight, vol. 4, no. 21, e131206. https://doi.org/10.1172/jci.insight.131206
Eric Kerchberger V, Bastarache JA, Shaver CM, Nagata H, Brennan McNeil J, Landstreet SR et al. Haptoglobin-2 variant increases susceptibility to acute respiratory distress syndrome during sepsis. JCI Insight. 2019 Nov 1;4(21). e131206. https://doi.org/10.1172/jci.insight.131206
Eric Kerchberger, V. ; Bastarache, Julie A. ; Shaver, Ciara M. ; Nagata, Hiromasa ; Brennan McNeil, J. ; Landstreet, Stuart R. ; Putz, Nathan D. ; Kuang Yu, Wen ; Jesse, Jordan ; Wickersham, Nancy E. ; Sidorova, Tatiana N. ; Janz, David R. ; Parikh, Chirag R. ; Siew, Edward D. ; Ware, Lorraine B. / Haptoglobin-2 variant increases susceptibility to acute respiratory distress syndrome during sepsis. In: JCI Insight. 2019 ; Vol. 4, No. 21.
@article{210c746834f040dda82eaef008a363fe,
title = "Haptoglobin-2 variant increases susceptibility to acute respiratory distress syndrome during sepsis",
abstract = "Acute respiratory distress syndrome (ARDS) is an inflammatory lung disorder that frequently complicates critical illness and commonly occurs in sepsis. Although numerous clinical and environmental risk factors exist, not all patients with risk factors develop ARDS, raising the possibility of genetic underpinnings for ARDS susceptibility. We have previously reported that circulating cell-free hemoglobin (CFH) is elevated during sepsis, and higher levels predict worse outcomes. Excess CFH is rapidly scavenged by haptoglobin (Hp). A common HP genetic variant, HP2, is unique to humans and is common in many populations worldwide. HP2 haptoglobin has reduced ability to inhibit CFH-mediated inflammation and oxidative stress compared with the alternative HP1. We hypothesized that HP2 increases ARDS susceptibility during sepsis when plasma CFH levels are elevated. In a murine model of sepsis with elevated CFH, transgenic mice homozygous for Hp2 had increased lung inflammation, pulmonary vascular permeability, lung apoptosis, and mortality compared with wild-Type mice. We then tested the clinical relevance of our findings in 496 septic critically ill adults, finding that HP2 increased ARDS susceptibility after controlling for clinical risk factors and plasma CFH. These observations identify HP2 as a potentially novel genetic ARDS risk factor during sepsis and may have important implications in the study and treatment of ARDS.",
author = "{Eric Kerchberger}, V. and Bastarache, {Julie A.} and Shaver, {Ciara M.} and Hiromasa Nagata and {Brennan McNeil}, J. and Landstreet, {Stuart R.} and Putz, {Nathan D.} and {Kuang Yu}, Wen and Jordan Jesse and Wickersham, {Nancy E.} and Sidorova, {Tatiana N.} and Janz, {David R.} and Parikh, {Chirag R.} and Siew, {Edward D.} and Ware, {Lorraine B.}",
year = "2019",
month = "11",
day = "1",
doi = "10.1172/jci.insight.131206",
language = "English",
volume = "4",
journal = "JCI insight",
issn = "2379-3708",
publisher = "The American Society for Clinical Investigation",
number = "21",

}

TY - JOUR

T1 - Haptoglobin-2 variant increases susceptibility to acute respiratory distress syndrome during sepsis

AU - Eric Kerchberger, V.

AU - Bastarache, Julie A.

AU - Shaver, Ciara M.

AU - Nagata, Hiromasa

AU - Brennan McNeil, J.

AU - Landstreet, Stuart R.

AU - Putz, Nathan D.

AU - Kuang Yu, Wen

AU - Jesse, Jordan

AU - Wickersham, Nancy E.

AU - Sidorova, Tatiana N.

AU - Janz, David R.

AU - Parikh, Chirag R.

AU - Siew, Edward D.

AU - Ware, Lorraine B.

PY - 2019/11/1

Y1 - 2019/11/1

N2 - Acute respiratory distress syndrome (ARDS) is an inflammatory lung disorder that frequently complicates critical illness and commonly occurs in sepsis. Although numerous clinical and environmental risk factors exist, not all patients with risk factors develop ARDS, raising the possibility of genetic underpinnings for ARDS susceptibility. We have previously reported that circulating cell-free hemoglobin (CFH) is elevated during sepsis, and higher levels predict worse outcomes. Excess CFH is rapidly scavenged by haptoglobin (Hp). A common HP genetic variant, HP2, is unique to humans and is common in many populations worldwide. HP2 haptoglobin has reduced ability to inhibit CFH-mediated inflammation and oxidative stress compared with the alternative HP1. We hypothesized that HP2 increases ARDS susceptibility during sepsis when plasma CFH levels are elevated. In a murine model of sepsis with elevated CFH, transgenic mice homozygous for Hp2 had increased lung inflammation, pulmonary vascular permeability, lung apoptosis, and mortality compared with wild-Type mice. We then tested the clinical relevance of our findings in 496 septic critically ill adults, finding that HP2 increased ARDS susceptibility after controlling for clinical risk factors and plasma CFH. These observations identify HP2 as a potentially novel genetic ARDS risk factor during sepsis and may have important implications in the study and treatment of ARDS.

AB - Acute respiratory distress syndrome (ARDS) is an inflammatory lung disorder that frequently complicates critical illness and commonly occurs in sepsis. Although numerous clinical and environmental risk factors exist, not all patients with risk factors develop ARDS, raising the possibility of genetic underpinnings for ARDS susceptibility. We have previously reported that circulating cell-free hemoglobin (CFH) is elevated during sepsis, and higher levels predict worse outcomes. Excess CFH is rapidly scavenged by haptoglobin (Hp). A common HP genetic variant, HP2, is unique to humans and is common in many populations worldwide. HP2 haptoglobin has reduced ability to inhibit CFH-mediated inflammation and oxidative stress compared with the alternative HP1. We hypothesized that HP2 increases ARDS susceptibility during sepsis when plasma CFH levels are elevated. In a murine model of sepsis with elevated CFH, transgenic mice homozygous for Hp2 had increased lung inflammation, pulmonary vascular permeability, lung apoptosis, and mortality compared with wild-Type mice. We then tested the clinical relevance of our findings in 496 septic critically ill adults, finding that HP2 increased ARDS susceptibility after controlling for clinical risk factors and plasma CFH. These observations identify HP2 as a potentially novel genetic ARDS risk factor during sepsis and may have important implications in the study and treatment of ARDS.

UR - http://www.scopus.com/inward/record.url?scp=85077608102&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85077608102&partnerID=8YFLogxK

U2 - 10.1172/jci.insight.131206

DO - 10.1172/jci.insight.131206

M3 - Article

C2 - 31573976

AN - SCOPUS:85077608102

VL - 4

JO - JCI insight

JF - JCI insight

SN - 2379-3708

IS - 21

M1 - e131206

ER -